Alerts will be sent to your verified email
Verify Email
CAMLIN-RE
|
CAMLIN-RE
|
JG Chemicals
|
Eiko Lifesciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
n/a | 19.16 % | -16.62 % |
|
5yr Avg Net Profit Margin
|
n/a | 6.22 % | -3.7 % |
|
Price to Book
|
0.0 | 3.89 | 1.27 |
|
P/E
|
0.0 | 27.99 | 27.05 |
|
5yr Avg Cash Conversion Cycle
|
n/a | 84.89 Days | 61.48 Days |
|
5yr Average Interest Coverage Ratio
|
n/a | 23.71 | -0.09 |
|
5yr Avg ROCE
|
n/a | 29.01 % | -109.51 % |
|
5yr Avg Operating Profit Margin
|
n/a | 8.98 % | -9.68 % |
|
5 yr average Debt to Equity
|
n/a | 0.34 | 0.3 |
|
5yr CAGR Net Profit
|
n/a | 22.26 % | 60.2 % |
|
5yr Average Return on Assets
|
n/a | 12.9 % | -4.56 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
n/a | 70.99 % | 36.74 % |
|
Share Pledged by Promoters
|
n/a | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
n/a | 0.0 | 23.26 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
n/a | 0.0 | 0.0 |
|
CAMLIN-RE
|
JG Chemicals
|
Eiko Lifesciences
|
|---|